Single Brain Scan Could Predict Risk of Age-Related Conditions Like Dementia

A new MRI-based biomarker, DunedinPACNI, developed by researchers, can predict individual aging rates from a single brain scan at midlife, enabling early intervention for age-related diseases like dementia.
Could a single brain scan predict the risk of age-related conditions like dementia?
An innovative MRI-based biomarker called DunedinPACNI has been developed by researchers from Duke, Harvard, and the University of Otago, which can predict how quickly an individual ages based on a single brain scan performed around age 45. This method not only estimates brain age but also correlates with systemic health and cognitive decline, potentially serving as a non-invasive indicator of overall biological aging.
Scientists found that higher DunedinPACNI scores align with indicators of rapid aging, such as poorer physical and cognitive health, and older physical appearance. The biomarker has shown promising results in validation across large datasets like the UK Biobank and ADNI, outperforming traditional MRI measures such as hippocampal volume. However, further validation across diverse populations is necessary.
This breakthrough offers the possibility of early detection of accelerated aging, enabling timely lifestyle interventions to delay or prevent age-related diseases like dementia. Experts believe that understanding one’s biological age through such scans can motivate proactive health measures, potentially improving longevity and quality of life.
While still in the research phase, DunedinPACNI represents a significant step toward integrating neuroimaging into personalized aging and health management strategies.
"This tool could be a game-changer in early aging detection, helping individuals and clinicians take proactive steps to improve health outcomes." – Expert opinion
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Comprehensive Overview of Breast Cancer Care in Ethiopia: Diagnosis, Treatment, and Survivorship Support
Discover how Ethiopia is advancing breast cancer diagnosis, treatment, and culturally tailored psychosocial support to improve patient survivorship outcomes.
Promising Results from DeLLphi-303: Safety and Survival in Extensive-Stage Small Cell Lung Cancer
Clinical trial results reveal an acceptable safety profile and unprecedented survival rates in patients with extensive-stage small cell lung cancer treated with tarlatamab combined with anti-PD-L1 therapy, marking a significant advance in lung cancer research.
Advanced CRISPR Technology Enables Large-Scale Gene Screening in Live Mouse Brains
A groundbreaking CRISPR platform enables large-scale gene screening directly in live mouse brains, advancing neurogenetic research and potential therapies.
FDA Grants Full Approval to Novavax COVID-19 Vaccine for High-Risk Adults
The FDA has fully approved Novavax's COVID-19 vaccine for adults aged 65+ and high-risk individuals aged 12-64, marking a milestone for protein-based COVID vaccination in the U.S.